Institutional members access full text with Ovid®

Resilience Is Associated With Fatigue After Mild Traumatic Brain Injury

Losoi, Heidi MA Psych; Wäljas, Minna Psych L; Turunen, Senni MA Psych; Brander, Antti MD, PhD; Helminen, Mika MSc; Luoto, Teemu M. MD; Rosti-Otajärvi, Eija PhD; Julkunen, Juhani PhD; Öhman, Juha MD, PhD

Journal of Head Trauma Rehabilitation: May/June 2015 - Volume 30 - Issue 3 - p E24–E32
doi: 10.1097/HTR.0000000000000055
Original Articles

Objective: To examine resilience as a predictor of change in self-reported fatigue after mild traumatic brain injury (MTBI).

Participants: A consecutive series of 67 patients with MTBI and 34 orthopedic controls. Design: Prospective longitudinal study.

Main Measures: Resilience Scale, Beck Depression Inventory–Second Edition, and Pain subscale from Ruff Neurobehavioral Inventory 1 month after injury and Barrow Neurological Institute Fatigue Scale 1 and 6 months after injury.

Results: Insomnia, pain, and depressive symptoms were significantly correlated with fatigue, but even when these variables were controlled for, resilience significantly predicted the change in fatigue from 1 to 6 months after MTBI. In patients with MTBI, the correlation between resilience and fatigue strengthened during follow-up. In controls, significant associations between resilience and fatigue were not found.

Conclusion: Resilience is a significant predictor of decrease in self-reported fatigue following MTBI. Resilience seems to be a relevant factor to consider in the management of fatigue after MTBI along with the previously established associated factors (insomnia, pain, and depressive symptoms).

Department of Neurosciences and Rehabilitation (Mss Losoi, Wäljas, and Turunen and Drs Luoto, Rosti-Otajärvi, and Öhman), and Medical Imaging Center, Department of Radiology (Dr Brander), Tampere University Hospital, Tampere, Finland; University of Helsinki, Institute of Behavioural Sciences, Helsinki, Finland (Ms Losoi and Dr Julkunen); School of Health Sciences, University of Tampere, Tampere, Finland (Mr Helminen); and Science Center, Pirkanmaa Hospital District, Tampere, Finland (Mr Helminen).

Corresponding Author: Heidi Losoi, MA Psych, Tampere University Hospital, PO Box 2000, FI-33521 Tampere, Finland (heidi.losoi@pshp.fi).

The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection.

The authors declare no conflicts of interest.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.